Who owns the KNACK PHARMA trademark?

The KNACK PHARMA trademark is owned by Knack Pharmaceuticals, Inc..

What is the serial number for KNACK PHARMA?

The USPTO serial number for KNACK PHARMA is 97425869.

What is the registration number for KNACK PHARMA?

KNACK PHARMA is registered under USPTO registration number 0.

KNA

USPTO Trademark Record

PENDING

KNACK PHARMA

Q: What class is the KNACK PHARMA trademark registered in?

The KNACK PHARMA trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services).

SN 97425869·Reg 0·Filed May 24, 2022

Owner Knack Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Advertising; business management, organization and administration; office functions.

KNACK PHARMA (Serial No. 97425869), Registration No. 0, is a pending US trademark filed on May 24, 2022 by Knack Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services).

Mark Intelligence

KNACK PHARMA (Reg. #0) is a pending US trademark that was filed in 2022 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 035 (Advertising, business management & retail services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 24, 2022

SERIAL

97425869

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

Knack Pharmaceuticals, Inc.

Entity

Corporation

State

Address

885 Third Avenue, 17th Floor, New York, NY, 10022

Country

Attorney

NameTomas M. Casalins

Law firm

Tomas M. Casalins FOX HORAN & CAMERINI LLP

Address

885 THIRD AVENUE, 17TH FLOOR, NEW YORK, NY 10022, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateMay 24, 2022

Serial Number97425869

Registration No.0

Registration DateDec 31, 1969

Status DateJul 24, 2026

Published for OppositionAug 11, 2026

Mark TypeStandard characters

Status DescriptionLive and pending, withdrawn before publication

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

Advertising; business management, organization and administration; office functions.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

46 events

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Jul 24, 2026

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

Jul 21, 2026

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

ASSIGNED TO EXAMINER

Jul 21, 2026

ASSIGNED TO EXAMINER

NOTICE OF ALLOWANCE CANCELLED

Jul 21, 2026

NOTICE OF ALLOWANCE CANCELLED

CASE RETURNED TO EXAMINATION

Jul 21, 2026

CASE RETURNED TO EXAMINATION

TEAS RESPONSE TO PETITION INQUIRY LETTER

Jul 13, 2026

TEAS RESPONSE TO PETITION INQUIRY LETTER

PETITION INQUIRY LETTER ISSUED

Jul 07, 2026

PETITION INQUIRY LETTER ISSUED

ASSIGNED TO PETITION STAFF

Jul 06, 2026

ASSIGNED TO PETITION STAFF

REVIEW OF CORRESPONDENCE COMPLETE

May 20, 2026

REVIEW OF CORRESPONDENCE COMPLETE

TEAS POST PUBLICATION AMENDMENT RECEIVED

May 19, 2026

TEAS POST PUBLICATION AMENDMENT RECEIVED

TEAS PETITION TO AMEND BASIS RECEIVED

May 18, 2026

TEAS PETITION TO AMEND BASIS RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 09, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 5 GRANTED

May 08, 2026

SOU EXTENSION 5 GRANTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

May 08, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU TEAS EXTENSION RECEIVED

Dec 10, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Dec 09, 2025

SOU EXTENSION 5 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 21, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jun 20, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

Jun 20, 2025

SOU EXTENSION 4 FILED

SOU EXTENSION 4 GRANTED

Jun 20, 2025

SOU EXTENSION 4 GRANTED

SOU EXTENSION 3 GRANTED

Dec 14, 2024

SOU EXTENSION 3 GRANTED

SOU EXTENSION 3 FILED

Dec 14, 2024

SOU EXTENSION 3 FILED

SOU TEAS EXTENSION RECEIVED

Dec 13, 2024

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 13, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jun 18, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Jun 18, 2024

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Jun 18, 2024

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 18, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

ASSIGNED TO EXAMINER

May 01, 2024

ASSIGNED TO EXAMINER

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 21, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Dec 19, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Dec 19, 2023

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Dec 19, 2023

SOU EXTENSION 1 GRANTED

ASSIGNED TO EXAMINER

Nov 13, 2023

ASSIGNED TO EXAMINER

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 20, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 25, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 25, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 05, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 20, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Mar 16, 2023

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Mar 16, 2023

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 16, 2023

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Mar 16, 2023

EXAMINER'S AMENDMENT ENTERED

ASSIGNED TO EXAMINER

Mar 12, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 31, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

May 27, 2022

NEW APPLICATION ENTERED

KNACK PHARMA

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Knack Pharmaceuticals, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Tomas M. Casalins

Resources

Company